Patients with intractable epilepsy have low melatonin, which increases following seizures.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 11113238.
- Also identified by PMC identifier 5020701.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Melatonin, which is used to treat sleep disorders, has anticonvulsant properties. The authors measured salivary melatonin and cortisol, at baseline and following seizures, in patients with intractable temporal lobe epilepsy and controls. Melatonin was reduced in patients with epilepsy at baseline compared with controls, and increased threefold following seizures. Cortisol also increased following seizures. Patients with intractable epilepsy have low baseline melatonin levels that increase dramatically following seizures.
Medical subject headings
- Epilepsy
- Melatonin